International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry

European Journal of Heart Failure
Gerasimos FilippatosMihai Gheorghiade

Abstract

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF (International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure) is a global, prospective, and observational study designed to characterize patient trajectories longitudinally during and following an index hospitalization for HF. Data collection for the registry will be conducted at ∼300 sites located in ∼40 countries. Comprehensive data including demographics, clinical presentation, co-morbidities, treatment patterns, quality of life, in-hospital and post-discharge outcomes, and health utilization and costs will be collected. Enrolment of ∼20 000 adult patients hospitalized with new-onset (first diagnosis) HF or decompensation of chronic HF over a 3-year period is planned with subsequent 3 years follow-up. The REPORT-HF registry will explore the clinical characteristics, management, and outcomes of HF worldwide. This global research programme may have implications for the formulation of public health policy and the design and conduct of international clin...Continue Reading

References

Apr 12, 2000·Journal of the American College of Cardiology·C P GreenJ A Spertus
May 30, 2001·European Journal of Heart Failure·A K AgarwalD de Bono
Mar 14, 2003·European Heart Journal·J G F ClelandUNKNOWN Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology
Sep 27, 2006·European Heart Journal·Markku S NieminenUNKNOWN Heart Failure Association, European Society of Cardiology
Nov 9, 2006·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN OPTIMIZE-HF Investigators and Coordinators
Feb 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuji OkuraYoshifusa Aizawa
Jul 16, 2010·Heart Failure Clinics·W H Wilson Tang, P S Daniel Yeo
Sep 2, 2010·European Journal of Heart Failure·Aldo P MaggioniUNKNOWN Heart Failure Association of ESC (HFA)
Dec 27, 2011·Journal of Cardiac Failure·John J AthertonUNKNOWN ADHERE International–Asia Pacific Scientific Advisory Committee
Jan 19, 2012·Circulation. Cardiovascular Quality and Outcomes·Véronique L Roger, Christopher J O'Donnell
May 23, 2012·Circulation·Benjamin A SteinbergUNKNOWN Get With the Guidelines Scientific Advisory Committee and Investigators
Sep 5, 2012·Archives of Internal Medicine·Albertino DamascenoKaren Sliwa
Apr 10, 2013·European Journal of Heart Failure·Carolyn S P LamA Mark Richards
Apr 26, 2013·Circulation. Heart Failure·Paul A HeidenreichUNKNOWN Stroke Council
May 28, 2013·Health and Quality of Life Outcomes·Louise HumphreyAnna Strömberg
Aug 21, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuhiko Sakata, Hiroaki Shimokawa
Dec 20, 2013·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Feb 5, 2014·Journal of the American College of Cardiology·Andrew P AmbrosyMihai Gheorghiade
Apr 11, 2014·The New England Journal of Medicine·Bertram PittUNKNOWN TOPCAT Investigators
Apr 11, 2014·The New England Journal of Medicine·John J V McMurray, Christopher O'Connor
Jul 10, 2014·The New England Journal of Medicine·Marc A PfefferSonja M McKinlay

❮ Previous
Next ❯

Citations

Mar 30, 2016·Trends in Cardiovascular Medicine·Andre Terzic, Atta Behfar
Aug 21, 2015·European Journal of Heart Failure·Stephen J Greene, Mihai Gheorghiade
Jun 25, 2015·European Journal of Heart Failure·Manuel Montero-Perez-BarqueroLuis Manzano
Apr 9, 2015·European Journal of Heart Failure·Stephen J GreeneJaved Butler
Jun 22, 2016·European Journal of Heart Failure·John ParissisFilippos Triposkiadis
Nov 14, 2016·International Journal of Cardiology·Marco MetraAndrew J Stewart Coats
Jan 20, 2017·European Journal of Heart Failure·Giuseppe Boriani, Vincenzo Livio Malavasi
Aug 17, 2019·European Journal of Heart Failure·Jasper TrompCarolyn S P Lam
Apr 29, 2015·European Journal of Heart Failure·Marco Metra
May 6, 2020·Clinical Interventions in Aging·Alexandra Dădârlat-PopAnca Buzoianu

❮ Previous
Next ❯

Software Mentioned

REPORT
HF

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.